SIGRID Partners With Pure Pharmacy as its Exclusive Miami Retailer
02 Jan 2024
The Natural Silica-Based Supplement Effective at Controlling Blood Sugar and Weight is Now available at Pure Pharmacy
MIAMI, Jan. 2, 2024 /PRNewswire/ -- SIGRID's Glucose Stabiliser is now exclusively sold in Miami at independent pharmacy, Pure Pharmacy. With Pure Pharmacy's commitment to providing premium healthcare to its community of Miami Beach, the partnership is a testament to SIGRID's breakthrough innovation in metabolic research. As the first retail agreement for the Swedish biotechnology company, this is a continuation of SIGRID's launch into U.S. markets.
The addition of SIGRID to the Pure Pharmacy catalog comes at a time when many are either facing a Type 2 Diabetes diagnosis or are using GLP-1 drugs to lose weight and although these prescriptions can be effective, they come with a list of side effects. The supplement is designed for those transitioning from GLP-1 drugs to aid in maintaining weight and glucose levels as it's proven to work faster than leading Type 2 medications to manage blood sugar over time, is natural, requires no needles and no prescription.
"This is a remarkable leap forward in our initiative to present ourselves throughout the U.S. market and empower those seeking a healthier life," says Sana Alajmovic, CEO of SIGRID. "Pure Pharmacy's emphasis on individualized care that empowers its customers to take control of their health is a direct reflection of our goals and are thrilled to have partnered with them."
"We strive at Pure Pharmacy to deliver the most premium treatment options and are excited our pharmacy is the exclusive Miami retailer to provide SIGRID," says Mishal Alsabbagh, founder of Pure Pharmacy. "The company's dedication to years of research and innovation with its SiPore® technology is the driving force behind our decision."
The Glucose Stabiliser is now available at Pure Pharmacy's store and website as well as the SIGRID website for $99. To learn more on how to best use the Glucose Stabiliser, talk to a Pure Pharmacy pharmacist and visit sigridstabiliser.com. For more information on Pure Pharmacy, visit purepharmacysobe.com.
About SIGRID
SIGRID's journey began in 2014. CEO, Sana Alajmovic and CSO, Prof. Tore Bengtsson established the biotechnology company upon a decade of extensive research and shared vision: to revolutionize the approach preventing chronic lifestyle diseases. SIGRID empowers people to transform their metabolism, for better health. For more information, visit sigridstabiliser.com.
Contact:
Sana Alajmovic
Co-founder & CEO, Sigrid Therapeutics
[email protected]
+46 72 3893396
SOURCE Sigrid Therapeutics
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.